Atlas Trials

Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC

Clinical trial NCT02436772 · COMPLETED

Trial details

NCT number
NCT02436772
Sponsor
SCRI Development Innovations, LLC
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Breast Cancer
Start date
2015-05-13
Primary completion
2017-07-07
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.